Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 170,019 | 146,633 | 118,697 | 153,225 | 95,697 |
| Receivables | 72,953 | 77,946 | 9,969 | 2,129 | N/A |
| Inventories | 9,643 | 7,817 | 1,813 | 1,316 | 0 |
| TOTAL | $255,720 | $237,512 | $133,484 | $158,575 | $96,883 |
| Non-Current Assets | |||||
| PPE Net | 11,854 | 9,274 | 1,826 | 1,038 | 738 |
| Intangibles | 29,503 | 44,255 | 0 | 2,103 | 0 |
| Other Non-Current Assets | 9,225 | 204 | 258 | 301 | 97 |
| TOTAL | $50,582 | $53,733 | $2,084 | $3,442 | $835 |
| Total Assets | $306,302 | $291,245 | $135,568 | $162,017 | $97,718 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,833 | 1,642 | 1,479 | 2,667 | 2,667 |
| Accounts payable and accrued liabilities | 6,247 | 12,150 | 5,684 | 9,106 | 3,537 |
| Accrued Expenses | 191,029 | 175,334 | 24,325 | 8,879 | 2,228 |
| TOTAL | $201,765 | $189,126 | $31,488 | $25,596 | $8,432 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,667 | 9,858 | 0 | 1,479 | 4,146 |
| Deferred Revenues | N/A | N/A | N/A | 4,944 | N/A |
| Other Non-Current Liabilities | 9,438 | 676 | 0 | 34 | 68 |
| TOTAL | $17,105 | $10,534 | $N/A | $1,513 | $4,214 |
| Total Liabilities | $218,870 | $199,660 | $31,488 | $27,109 | $12,646 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,051 | 33,305 | 32,994 | 29,449 | 23,507 |
| Common Shares | 34 | 33 | 33 | 29 | 21 |
| Retained earnings | -359,899 | -337,177 | -298,049 | -223,184 | -129,008 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | -3 |
| TOTAL | $87,432 | $91,585 | $104,080 | $134,908 | $85,072 |
| Total Liabilities And Equity | $306,302 | $291,245 | $135,568 | $162,017 | $97,718 |